Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  Edwards Lifesciences Corp    EW

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets 

Edwards Lifesciences Corp : Edwards Lifesciences to Host Earnings Conference Call on April 24, 2012

share with twitter share with LinkedIn share with facebook
share via e-mail
0
04/16/2012 | 10:28pm CEST

IRVINE, CA, April 16, 2012

To participate in the conference call, dial (877) 407-8037 or (201) 689-8037. For 72 hours following the call, an audio replay can be accessed by dialing (877) 660-6853 or (201) 612-7415 and using account number 2995 and conference number 392053. The call will also be available via live or archived webcast on the "Investor Relations" section of the Edwards web site at www.edwards.com or http://www.edwards.com/InvestorRelations/EventCalendar.htm.

About Edwards Lifesciences
Edwards Lifesciences is the global leader in the science of heart valves and hemodynamic monitoring. Driven by a passion to help patients, the company partners with clinicians to develop innovative technologies in the areas of structural heart disease and critical care monitoring that enable them to save and enhance lives. Additional company information can be found at www.edwards.com.

Edwards is a trademark of Edwards Lifesciences Corporation. Edwards Lifesciences and the stylized E logo are trademarks of Edwards Lifesciences Corporation and are registered in the United States Patent and Trademark Office.

# # #
distributed by
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on EDWARDS LIFESCIENCES CORP
05/19 EDWARDS LIFESCIENCES CORP (NYSE : EW) Reports Positive Outcome From Self-Expandi..
05/18 EDWARDS LIFESCIENCES' : Every Heartbeat Matters Initiative On Track To Impact 1 ..
05/17 EDWARDS LIFESCIENCES : ' Novel Self-Expanding Transcatheter Heart Valve Demonstr..
05/16 EDWARDS LIFESCIENCES : Real-World Evidence With Edwards SAPIEN 3 Transcatheter V..
05/12 EDWARDS LIFESCIENCES CORPORATION (NY : EW) Files An 8-K Departure of Directors o..
05/12 EDWARDS LIFESCIENCES CORP : Change in Directors or Principal Officers, Submissio..
05/11 EDWARDS LIFESCIENCES : Patent Issued for Systems and Methods for Placing a Coapt..
05/04 EDWARDS LIFESCIENCES : Trademark Application for "ENDORETURN" Filed by Edwards L..
05/04 EDWARDS LIFESCIENCES : Trademark Application for "TRUWAVE" Filed by Edwards Life..
05/04 EDWARDS LIFESCIENCES : To Webcast Annual Meeting Of Stockholders
More news
Sector news : Advanced Medical Equipment & Technology - NEC
02:15pDJCompanies Are Winning the Battle Over Adjusted Earnings
05/17 PHILIPS CEO : uptake of connected care products progressing slowly
05/15DJMARKET SNAPSHOT : Stock Market Sets Fresh Records As Oil Rallies
05/15 Thermo Fisher to buy Patheon for $5.2 billion to expand biopharma services
05/15DJMARKET SNAPSHOT : Stock Market Sets New Records As Oil Rallies
More sector news : Advanced Medical Equipment & Technology - NEC
News from SeekingAlpha
05/16 Lotus Blooms In Phase III
05/16 Edwards' SAPIEN 3 valve shows significant treatment benefit in large post-mar..
05/16 Premarket analyst action - healthcare
05/08 VALUATION DASHBOARD : Healthcare - Update
05/04 Best-Performing Stocks On Earnings This Season
Advertisement
Financials ($)
Sales 2017 3 349 M
EBIT 2017 1 006 M
Net income 2017 777 M
Finance 2017 472 M
Yield 2017 -
P/E ratio 2017 31,48
P/E ratio 2018 28,54
EV / Sales 2017 6,93x
EV / Sales 2018 6,24x
Capitalization 23 685 M
More Financials
Chart EDWARDS LIFESCIENCES CORP
Duration : Period :
Edwards Lifesciences Corp Technical Analysis Chart | EW | US28176E1082 | 4-Traders
Full-screen chart
Technical analysis trends EDWARDS LIFESCIEN...
Short TermMid-TermLong Term
TrendsBullishBullishNeutral
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 22
Average target price 121 $
Spread / Average Target 7,0%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Michael A. Mussallem Chairman & Chief Executive Officer
Scott B. Ullem Chief Financial Officer & Vice President
Stanton J. Rowe Chief Scientific Officer & VP-Advanced Technology
John T. Cardis Independent Director
William J. Link Independent Director
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
EDWARDS LIFESCIENCES C..20.48%23 685
THERMO FISHER SCIENTIF..21.57%67 106
DANAHER CORPORATION5.52%57 015
BOSTON SCIENTIFIC CORP..22.10%36 166
PHILIPS9.05%32 940
INTUITIVE SURGICAL, IN..37.24%32 064
More Results